| 
						
						
						 Obama 
						tax inversion rules may overstep authority: U.S. 
						lawmaker 
		 Send a link to a friend 
		[April 16, 2016] 
		By David Morgan
 WASHINGTON (Reuters) - President Barack 
		Obama's proposed rules to stop U.S. companies from reincorporating 
		abroad, if only on paper, to avoid U.S. income taxes appear to overstep 
		legal authority, a top Republican lawmaker said on Friday.
 | 
			
            | 
			
			 Representative Kevin Brady said his staff is scrutinizing the rules, 
			which were unveiled last week by the U.S. Treasury Department. Legal 
			experts have offered mixed views on the viability of any court 
			challenge. 
 The new rules, intended to discourage tax "inversions," led to the 
			collapse of U.S. drugmaker Pfizer Inc's $160 billion acquisition of 
			Ireland's Allergan Plc.
 
 "We recognize there is broad discretion in some areas of that tax 
			code," Brady, a Texas Republican and chairman of the tax-writing 
			House of Representatives Ways and Means Committee, said in a speech 
			to the U.S. Chamber of Commerce.
 
			
			 
			"But it certainly appears that Treasury overstepped its authority, 
			especially in effect, taking legislative proposals that haven’t 
			passed this Congress or any other Congress and essentially making it 
			law through regulation."
 Brady gave no indication of what his committee might do. It was 
			unclear what action, if any, the Republican-controlled Congress 
			would take against the inversion rules in an election year marked by 
			voter anger over taxes and international trade.
 
 "I share the concern about inversions. Everyone does. But there’s a 
			right way and a wrong way to tackle them," Brady said.
 
 An inversion is a tax-driven deal in which a U.S. company acquires a 
			smaller, foreign business and adopts its tax domicile to reduce the 
			combined company's overall tax burden. The deals most often involve 
			reincorporating in Ireland or Britain.
 
			
            [to top of second column] | 
            
			
 
			Though inversions have been going since the 1980s, a new wave has 
			been under way for about five years. The Pfizer-Allergan deal would 
			have been the biggest inversion of all time.
 There is bipartisan agreement on the need for comprehensive tax 
			reform to address inversions, but the deeply divided Congress is 
			unlikely to tackle this until 2017, especially with elections coming 
			in November, analysts said.
 
 In the interim, the Obama administration has tightened inversion 
			rules in limited areas, drawing Republican criticism.
 
 "The administration’s strategy won’t solve the fundamental problem 
			and likely will make it worse," Brady said.
 
 (Editing by Steve Orlofsky and Andrew Hay)
 
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
			
			
			 
			
			 |